Naltrexone is mostly used to help people addicted to opioid drugs safely withdraw from them, but LDN is used for a far different purpose. By temporarily blocking opioid receptors, LDN, in effect, unleashes them – causing a rebound effect and an increase in the...
Cortene’s appearance in the chronic fatigue syndrome (ME/CFS) world a couple of years ago was like a breath of fresh air. The small drug company wanted to do something unusual in the annals of this neglected disease – run a clinical trial – and not...
Whitney Dafoe’s painstaking and illuminating characterization of his descent into a severe illness, “Extremely Severe ME/CFS—A Personal Account”, was recently published in an edition of the Healthcare Journal that was devoted to severely ME/CFS...
(My apologies for those who got two email blasts. I’m not sure how that happened.) In this hour plus Q&A with Sheffield ME and Fibromyalgia Group I got to blab about hot topics in fibromyalgia research, hope for future treatments, how chronic fatigue...
The US ME/CFS Clinician Coalition Created in 2018 by a group of U.S. physicians, the US ME/CFS Clinician Coalition is dedicated to advancing best medical practices to medical providers on how to best diagnose and treat ME/CFS. Since 2018, the word has gotten out and...
Abilify (Aripiprazole) might seem to be the last thing that could help someone with chronic fatigue syndrome (ME/CFS). Abilify is a second-generation antipsychotic that is FDA approved for schizophrenia but is used off-label for depression, Parkinson’s disease,...
